Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a child's doctor visit spark a parent's quit-smoking journey?

NCT ID NCT06582693

Prevention Sponsor: Children's Hospital of Philadelphia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests whether proactively connecting household smokers to quit-smoking resources through a child's pediatric care visit increases their use of evidence-based treatments and quit rates. Adult household members who smoke are offered options like nicotine replacement, varenicline, quitline support, or text-based programs, along with motivational counseling. The study compares this approach to usual care and also looks at factors that influence success.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Refer2Quit intervention: automatic connection to evidence-based tobacco treatments (varenicline, nicotine replacement therapy, quitline, smokefreeTXT) plus motivational counseling and text messaging
What this could lead to
If effective, this approach could help more household smokers quit, reducing secondhand smoke exposure for children and improving family health.
What could go wrong
The trial relies on self-reported quit rates and may not reach all smokers. Success depends on participant engagement, and results may not generalize beyond this pediatric network.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 3,200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Adult Intervention Subject Inclusion Criteria * Males or females ages ≥18 years in age * Self-identify as a current combustible tobacco user * Have a valid cell phone number Child Intervention Subject Inclusion Criteria * Must be a CHOP patient Adult Intervention Subject Exclusion Criteria * \<18 years in age. * Indicates no combustible tobacco smoking Child Intervention Subject Exclusion Criteria * Not a CHOP patient Adult Control Subject Inclusion Criteria * Males or females ages ≥18 years in age * Self-identify as a current combustible tobacco user * Have a valid cell phone number Child Control Subject Inclusion Criteria * Must be a CHOP patient Adult Control Subject Exclusion Criteria * \<18 years in age. * Indicates no combustible tobacco smoking Child Control Subject Exclusion Criteria * Not a CHOP patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Second hand tobacco smoke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

nicotine dependence Smoking Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Second hand tobacco smoke Smoking Smoking cessation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19146, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.